Cloud over sentinel node biopsy: unlikely survival benefit in melanoma

Affiliations

Comment

Urbà González. Arch Dermatol. 2007 Jun.

. 2007 Jun;143(6):775-6.

doi: 10.1001/archderm.143.6.775.

¹ Department of Dermatology, Research Unit for Evidence-Based Dermatology, Clinica Plató, C/Plató 21, 08006 Barcelona, Spain. urba.gonzalez@clinicaplato.com

No abstract available

Comment in

The current status of evaluation and treatment of high-risk cutaneous melanoma: therapeutic breakthroughs remain elusive.
Kanzler MH. Kanzler MH. Arch Dermatol. 2007 Jun;143(6):785-7. doi: 10.1001/archderm.143.6.785. Arch Dermatol. 2007. PMID: 17576947 No abstract available.
Sentinel node biopsy: facts to clear the alleged clouds.
Morton DL, Elashoff R. Morton DL, et al. Arch Dermatol. 2008 May;144(5):685-6; author reply 687. doi: 10.1001/archderm.144.5.685. Arch Dermatol. 2008. PMID: 18490604 No abstract available.

Sentinel-node biopsy or nodal observation in melanoma.
Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Glass EC, Wang HJ; MSLT Group. Morton DL, et al. N Engl J Med. 2006 Sep 28;355(13):1307-17. doi: 10.1056/NEJMoa060992. N Engl J Med. 2006. PMID: 17005948 Clinical Trial.